Disease-modifying therapies for multiple sclerosis: Focus on future direction


Multiple sclerosis (MS) is a neurologic disorder of chronic inflammation and demyelination of the central nervous system. Several additional agents, including oral products, are now under investigation for the future treatment of MS.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.